Generally tend to agree with your analysis here. I did my Base/Covid split at the EBITDA line as the depreciation charge doesn't seem to be influenced that much by the Base/Covid revenue mix. Using some pretty soft assumptions for H2 a $1.0B EBIT figure for the full year seems reasonable. However, do your own research and form your own views.
Generally tend to agree with your analysis here. I did my...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.74 |
Change
0.200(0.75%) |
Mkt cap ! $12.84B | |||
| Open | High | Low | Value | Volume |
| $26.75 | $26.92 | $26.58 | $32.18M | 1.204M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1463 | $26.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.75 | 5455 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| SHL (ASX) Chart |